Results 11 to 20 of about 2,112,760 (151)

The Transumbilical Laparoendoscopic Single-Site Extraperitoneal Approach for Pelvic and Para-Aortic Lymphadenectomy: A Technique Note and Feasibility Study

Frontiers in Surgery, 2022
BackgroundNowadays, lymphadenectomy could be performed by the transperitoneal or extraperitoneal approach. Nevertheless, each approach has its own advantages and disadvantages.
Shiyi Peng, Shiyi Peng, Ying Zheng, Ying Zheng, Fan Yang, Fan Yang, Kana Wang, Kana Wang, Sijing Chen, Sijing Chen, Yawen Wang   +10 more
doaj   +1 more source

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation

Frontiers in Oncology, 2021
ObjectiveTo evaluate the role of sentinel lymph node biopsy (SLNB) to avoid staging lymphadenectomies by detecting nodal metastasis in intermediate- and high-risk endometrial cancer (EC).MethodsA single institutional retrospective study was performed ...
Virginia García Pineda, Ignacio Zapardiel, Myriam Gracia, Jaime Siegrist, María Dolores Diestro, María Alonso, Alicia Hernández   +6 more
doaj   +1 more source

Systematic Pelvic and Para-Aortic Lymphadenectomy During Fertility-Sparing Surgery in Patients With Early-Stage Epithelial Ovarian Cancer: A Retrospective Study

Frontiers in Oncology, 2022
ObjectiveThe implication of pelvic and para-aortic lymphadenectomy in surgical staging of early-stage epithelial ovarian cancer (eEOC) is still debated. Limited data are available about systematic lymphadenectomy during fertility-sparing surgery (FSS) in
Tingting Li, Tingting Li, Ya Liu, Ya Liu, Sixia Xie, Sixia Xie, Hongjing Wang, Hongjing Wang   +7 more
doaj   +1 more source

Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes

Clinical and Experimental Obstetrics & Gynecology, 2023
Background: This study aimed to evaluate the effectiveness of pelvic and para-aortic lymphadenectomy in patients with advanced epithelial ovarian cancer following neoadjuvant chemotherapy. Methods: This single-center retrospective study analyzed patients
Michiko Kubo-Kaneda, Eiji Kondo, Naosuke Enomoto, Kota Okamoto, Kuniaki Toriyabe, Masafumi Nii, Kenta Yoshida, Tomoaki Ikeda   +7 more
doaj   +1 more source

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

Medicina, 2022
Background and Objectives: We aimed to evaluate Progression Free Survival (PFS), Overall Survival (OS), and relapse rate in women affected by endometrioid ovarian cancer and synchronous endometrial-ovarian endometrioid cancer (SEO-EC).
Basilio Pecorino, Antonio Simone Laganà, Vito Chiantera, Martina Ferrara, Andrea Benedetto Di Stefano, Mariano Catello Di Donna, Felice Sorrentino, Luigi Nappi, Mislav Mikuš, Paolo Scollo   +9 more
doaj   +1 more source

The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients

BMC Cancer, 2020
Background Systematic retroperitoneal lymphadenectomy has been widely used in the surgical treatment of advanced ovarian cancer patients. Nevertheless, the corresponding therapeutic may not provide a survival benefit.
Chenyan Fang, Yingli Zhang, Lingqin Zhao, Xi Chen, Liang Xia, Ping Zhang   +5 more
doaj   +1 more source

Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials

World Journal of Surgical Oncology, 2022
Background The debate surrounding systematic lymphadenectomy in the epithelial cancers of the ovary (EOC) was temporarily put to rest by the LION trial.
Roli Purwar, Rakesh Ranjan, Kishan Soni, Manoj Pandey, Satyanshu K. Upadhyay, Esha Pai, Tarun Kumar   +6 more
doaj   +1 more source

Lymph nodes dissection in advanced ovarian cancer

Репродуктивная эндокринология, 2020
Ovarian cancer becomes the most aggressive disease among all cancer pathology in women’s reproductive system. Surgery and chemotherapy are the main options on the way of ovarian cancer treatment.
V. S. Svintsitskiy, N. P. Tsip, S. V. Nespryadko, V. I. Kopetskyi, M. Y. Yegorov, O. M. Movchan, O. P. Renkas, O. I. Bubliieva   +7 more
doaj   +1 more source

Lymphadenectomy in Primary Fallopian Tube Cancer is Associated with Improved Survival

Journal of Investigative Surgery, 2022
Background and Objectives Primary fallopian tube cancer (PFTC) shares the same diagnostic and management guidelines with epithelial ovarian cancer (EOC).
Yao Xiao, Yue-xi Liu, Ruo-nan Li, Xing Wei, Qing-miao Wang, Qiu-ying Gu, Hua Linghu   +6 more
doaj   +1 more source

Update of sentinel lymph node mapping assessment in endometrial cancer

Gynecology and Obstetrics Clinical Medicine, 2023
Endometrial cancer is the most common gynecologic malignancy in developed countries. Pathologic confirmation of lymph node metastasis is important for risk stratification and the administration of adjuvant treatments. Therefore, comprehensive, systematic
Se Ik Kim, Jae-Weon Kim
doaj   +1 more source